INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

BIT:1ISRG • US46120E6023

410.85 EUR
-57.35 (-12.25%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

7

Taking everything into account, 1ISRG scores 7 out of 10 in our fundamental rating. 1ISRG was compared to 67 industry peers in the Health Care Equipment & Supplies industry. 1ISRG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. 1ISRG shows excellent growth, but is valued quite expensive already. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • 1ISRG had a positive operating cash flow in the past year.
  • Each year in the past 5 years 1ISRG has been profitable.
  • In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • 1ISRG's Return On Assets of 13.96% is amongst the best of the industry. 1ISRG outperforms 92.19% of its industry peers.
  • With an excellent Return On Equity value of 16.02%, 1ISRG belongs to the best of the industry, outperforming 84.38% of the companies in the same industry.
  • 1ISRG's Return On Invested Capital of 13.95% is amongst the best of the industry. 1ISRG outperforms 90.63% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1ISRG is above the industry average of 9.66%.
  • The 3 year average ROIC (12.43%) for 1ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1ISRG's Profit Margin of 28.38% is amongst the best of the industry. 1ISRG outperforms 96.88% of its industry peers.
  • In the last couple of years the Profit Margin of 1ISRG has grown nicely.
  • 1ISRG has a better Operating Margin (29.35%) than 98.44% of its industry peers.
  • In the last couple of years the Operating Margin of 1ISRG has grown nicely.
  • With a decent Gross Margin value of 66.00%, 1ISRG is doing good in the industry, outperforming 75.00% of the companies in the same industry.
  • 1ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
  • Compared to 1 year ago, 1ISRG has less shares outstanding
  • The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ISRG has an Altman-Z score of 41.32. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 41.32, 1ISRG belongs to the top of the industry, outperforming 98.44% of the companies in the same industry.
  • 1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 41.32
ROIC/WACC1.44
WACC9.7%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of 1ISRG (4.87) is better than 96.88% of its industry peers.
  • A Quick Ratio of 3.96 indicates that 1ISRG has no problem at all paying its short term obligations.
  • 1ISRG's Quick ratio of 3.96 is amongst the best of the industry. 1ISRG outperforms 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • 1ISRG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.83%, which is quite impressive.
  • 1ISRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.42% yearly.
  • Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 20.51%.
  • 1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.22% yearly.
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.00% on average over the next years. This is quite good.
  • 1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.91% yearly.
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 54.56, the valuation of 1ISRG can be described as expensive.
  • 1ISRG's Price/Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Earnings ratio is at 27.09. 1ISRG is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 47.68, the valuation of 1ISRG can be described as expensive.
  • Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 68.75% of the companies are valued more cheaply.
  • 1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 27.98, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 54.56
Fwd PE 47.68
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 65.63% of the companies are valued more cheaply.
  • 1ISRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 69.49
EV/EBITDA 45.27
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • 1ISRG has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.59% in the coming years.
PEG (NY)3.77
PEG (5Y)2.55
EPS Next 2Y14.31%
EPS Next 3Y14.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • 1ISRG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INTUITIVE SURGICAL INC

BIT:1ISRG (2/5/2026, 7:00:00 PM)

410.85

-57.35 (-12.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22
Earnings (Next)04-20
Inst Owners88.29%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap145.91B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts78.1
Price Target533.94 (29.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)4.89%
PT rev (3m)2.43%
EPS NQ rev (1m)0.17%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3%
EPS NY rev (3m)3.32%
Revenue NQ rev (1m)0.53%
Revenue NQ rev (3m)0.53%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 54.56
Fwd PE 47.68
P/S 17.2
P/FCF 69.49
P/OCF 57.11
P/B 9.71
P/tB 9.93
EV/EBITDA 45.27
EPS(TTM)7.53
EY1.83%
EPS(NY)8.62
Fwd EY2.1%
FCF(TTM)5.91
FCFY1.44%
OCF(TTM)7.19
OCFY1.75%
SpS23.89
BVpS42.31
TBVpS41.39
PEG (NY)3.77
PEG (5Y)2.55
Graham Number84.67
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 41.32
F-Score8
WACC9.7%
ROIC/WACC1.44
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)21.83%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%14.48%
EPS Next Y14.46%
EPS Next 2Y14.31%
EPS Next 3Y14.59%
EPS Next 5Y14%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%18.76%
Revenue Next Year15.92%
Revenue Next 2Y14.87%
Revenue Next 3Y14.63%
Revenue Next 5Y12.91%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year34.54%
EBIT Next 3Y22.15%
EBIT Next 5Y17.41%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 5 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 1 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


Can you provide the profitability details for INTUITIVE SURGICAL INC?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for 1ISRG stock?

The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 54.56 and the Price/Book (PB) ratio is 9.71.


Can you provide the financial health for 1ISRG stock?

The financial health rating of INTUITIVE SURGICAL INC (1ISRG.MI) is 7 / 10.